✕
Login
Register
Back to News
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est
Benzinga Newsdesk
www.benzinga.com
Positive 81.2%
Neg 0%
Neu 0%
Pos 81.2%
2026 Guidance
Full year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment